Clinical Trials Sponsored by Hangzhou First People Hospital

Total 1937 results

The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer

Advanced Colorectal Cancer
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Phase II Study of Tislelizumab as Adjuvant Therapy for Patients With Stage Ⅱ and Stage Ⅲ Colon Cancer and dMMR/MSI.

Colon Cancer
The First Affiliated Hospital of Zhengzhou University

Recruiting

An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer

Breast Cancer | Breast Cancer Female

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

AK105 Combined With Anlotinib in Patients With Cervical Cancer

Cervical Cancer
The First Affiliated Hospital of Zhengzhou University

Recruiting

Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Metastatic Gastric Cancer

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

Recurrent Glioma

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Primary Ovarian Insufficient Patients

Healthy Related

China
The First Affiliated Hospital of Zhengzhou University

Active, not recruiting

Tislelizumab in Addition to BACE in Patients With NSCLC

NSCLC

China
The First Affiliated Hospital of Zhengzhou University

Completed

Site Selection of Short Peripheral Venous Catheters (SPECIAL)

Short Peripheral Venous Catheter

China
The First Affiliated Hospital of Zhengzhou University

Unknown

Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Advanced Esophageal Squamous Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Unknown

The Application of Time-lapse System in IVF/ICSI

the Application of Time-lapes System in IVF/ICSI

China
The First Affiliated Hospital of Zhengzhou University

Unknown

The Effectiveness of Endometrial Injury in IVF

Infertility

China
People's Hospital of Zhengzhou University

Completed

An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM

Invasive Fungal Infection

China
People's Hospital of Zhengzhou University

Completed

PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic Nephropathy

T2DM (Type 2 Diabetes Mellitus)
People's Hospital of Zhengzhou University

Recruiting

Factors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly Patients

Invasive Fungal Infection

China
People's Hospital of Zhengzhou University

Completed

SREBP1 as a Potential Biomarker Promotes Cell Proliferation and Invasion in Thyroid Cancer

Thyroid Cancer

China
People's Hospital of Zhengzhou University

Completed

Loading Regimen，Serum Trough Concentrations，Efficacy and Safety in Pneumonia Patients With Gram-positive Infections

Pneumonia Gram-Positive Bacterial
People's Hospital of Zhengzhou University

Withdrawn

Intermittent Oro-esophageal Tube Feeding in Late Dysphagia for Nasopharyngeal Carcinoma

Dysphagia

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

Gastric Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)

Esophageal Squamous Cell Carcinoma (ESCC) | PD-1 Inhibitors

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer

Capecitabine | MSI-H Colorectal Cancer | Oxaliplatin | Tislelizumab
The First Affiliated Hospital of Zhengzhou University

Recruiting

Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract Cancer

Advanced Biliary Tract Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion

Malignant Pleural Effusion
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer

Gastric Cancer

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC

Esophageal Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Phase Ⅱ Clinical Trial of Camrelizumab for Adjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Resectable Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University

Recruiting

Newborns From Patients Treated With ART (Assisted Reproductive Technology)

Health Related

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Active, not recruiting

Anlotinib Combined With TQB2450 (PD-L1 Inhibitor) in the Treatment of Advanced Esophageal Squamous Cell Carcinoma(ESCC)

Esophageal Squamous Cell Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Unknown

Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCC

HCC

China
The First Affiliated Hospital of Zhengzhou University

Unknown

The Application of a New Ovarian Stimulation Protocol in IVF

Ovulation Induction | Clinical Pregnancy Rate

China
The First Affiliated Hospital of Zhengzhou University

Unknown

Drug-coated Balloon Angioplasty for Patients With Symptomatic Vertebral Artery Stenosis

Vertebral Artery Stenosis

China
The First Affiliated Hospital of Zhengzhou University

Unknown

A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure

Hepatocellular Carcinoma
The First Affiliated Hospital of Zhengzhou University

Unknown

Effect of Endometrial Thickness on IVF Outcome

Infertility

China
Second Affiliated Hospital of Guangzhou Medical...
First Affiliated Hospital, Sun Yat-Sen University; West China Hospital; Guangzhou... and other collaborators

Unknown

HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions

Epilepsy | Neuropathy | Blepharospasm | Psychiatric Illness

China
First Hospital of China Medical University
The Second Hospital of Shandong University; The First People's Hospital of... and other collaborators

Recruiting

Gut Microbiota and Metabonomics (MBS)

Stomach Neoplasms | Gut Microbiota | Metabolomics

China
Second Affiliated Hospital, School of Medicine,...
First People's Hospital of Hangzhou; China-Japan Friendship Hospital

Unknown

Clinical Trial of Ultrasound Combined With Computed Tomography Guided Lumbar Sympathetic Ganglion Block

Pain, Chronic | Ultrasound Therapy | Sympathetic Disorder

China
Changhai Hospital
First People's Hospital of Hangzhou; Tongji Hospital; Qilu Hospital of Shandong... and other collaborators

Unknown

Application of OE in Diagnosis of EGC

High Risk Population of Gastric Cancer

China
The Hong Kong Polytechnic University
Guangzhou First People's Hospital; Kowloon Hospital, Hong Kong; Tuen Mun Hospital and other collaborators

Completed

"Remind-to-move" for Promoting Upper Extremity Recovery in Patients With Stroke After Subacute Discharge

Stroke | Upper Extremity Hemiplegia
China Medical University, China
Liaoning Tumor Hospital & Institute; The First People's Hospital of Jingzhou

Not yet recruiting

Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
The First Affiliated Hospital of Anhui Medical...
Hangzhou Cancer Hospital

Completed

Endothelial Injury Mechanism in Elderly Patients Undergoing Major Surgery

Postoperative Cognitive Dysfunction | Endothelial Dysfunction | Blood Brain Barrier Defect

China
Guangzhou Medical University
The First Affiliated Hospital of Guangzhou Medical University

Completed

Personalized Therapy in Non-small Cell Lung Cancer (PTINCLC)

Lung Cancer | Carboplatin Adverse Reaction

China
Guangdong Provincial People's Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Zhongshan People's... and other collaborators

Unknown

Long-term MOno-Antiplatelet Drug Strategy After PerCutanEous CoronAry InterveNtion (RESCIND-OCEAN)

Antiplatelet Drug-related Gastrointestinal Injury

China
Second Affiliated Hospital, School of Medicine,...
First People's Hospital of Hangzhou; Zhejiang Provincial Hospital of TCM

Not yet recruiting

Low Dose Euthyrox in Treatments of Paraquat Intoxication. (LDETPI)

Paraquat Poisoning
The Third Affiliated hospital of Zhejiang Chinese...
First People's Hospital of Hangzhou; Zhejiang Provincial Tongde Hospital

Completed

Intradermal Acupuncture Based on Changes in Biological Specificity of Acupoints for Major Depressive Disorder

Major Depressive Disorder

China
Wuxi People's Hospital
Imbioray (Hangzhou) Biomedicine Co., Ltd.

Recruiting

Study of Anti-5T4 CAR-NK Cell Therapy in Advanced Solid Tumors

Advanced Solid Tumors

China
Taizhou Hospital
First Affiliated Hospital of Zhejiang University; Taizhou First People's Hospital and other collaborators

Unknown

A Multi-center Study for Eradication of Refractory Helicobacter Pylori

Gastritis

China
Wuxi People's Hospital
Imbioray (Hangzhou) Biomedicine Co., Ltd.

Recruiting

Study of Anti-CD33/CLL1 CAR-NK in Acute Myeloid Leukemia

Acute Myeloid Leukemia

China
Sun Yat-sen University
Guangzhou No.12 People's Hospital; Kaiping Central Hospital; ZhongShan People...

Recruiting

Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study

Hepatocellular Carcinoma

China
Guangzhou First People's Hospital
LanZhou University; Sun Yat-sen University; The Third Affiliated Hospital of... and other collaborators

Completed

HPA Antibodies and the Distribution of Antigen and Antibodies

Blood Disease | Antibody-mediated Rejection | Platelet Refractoriness

China

Clinical Trials Sponsored by Hangzhou First People Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations